Generation Investment Management LLP Buys New Shares in The Cooper Companies, Inc. $COO

Generation Investment Management LLP purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 4,968,673 shares of the medical device company’s stock, valued at approximately $356,304,000. Cooper Companies comprises 3.5% of Generation Investment Management LLP’s investment portfolio, making the stock its 10th largest holding.

Other large investors also recently bought and sold shares of the company. Danske Bank A S acquired a new position in shares of Cooper Companies in the 2nd quarter valued at $7,077,000. Diversify Advisory Services LLC acquired a new stake in shares of Cooper Companies during the 2nd quarter worth $1,704,000. Wealthfront Advisers LLC acquired a new stake in shares of Cooper Companies during the 2nd quarter worth $605,000. Figure 8 Investment Strategies LLC purchased a new position in shares of Cooper Companies in the 2nd quarter worth $626,000. Finally, Citizens Financial Group Inc. RI purchased a new position in shares of Cooper Companies in the 2nd quarter worth $747,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on COO shares. UBS Group initiated coverage on Cooper Companies in a research report on Tuesday, July 28th. They set a “neutral” rating and a $75.00 price target for the company. Mizuho set a $85.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a report on Thursday, June 4th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Finally, The Goldman Sachs Group set a $61.00 target price on Cooper Companies in a report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, Cooper Companies presently has an average rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Trading Up 1.3%

Shares of COO opened at $76.73 on Thursday. The stock’s 50-day moving average is $71.59 and its two-hundred day moving average is $71.16. The stock has a market cap of $14.96 billion, a PE ratio of 65.03, a P/E/G ratio of 1.98 and a beta of 0.83. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts forecast that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.